Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders

Deadline: January 15, 2017

The purpose of this Funding Opportunity Announcement (FOA) is to encourage Phased Innovation (R61/R33) grant applications that focus on psychosocial intervention development consistent with the NIMH emphasis on the experimental therapeutic approach for the treatment and prevention of mental disorders in adults and children. In this approach, clinical trials should be designed so that even negative results will provide information to guide further intervention development efforts.

Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions

Deadline: January 15, 2017

The purpose of this FOA is to support research to test the therapeutic value of treatment, preventive, and services strategies for which there is already evidence of efficacy, for use in community and practice settings and to test hypotheses regarding moderators, mediators, and mechanisms of action of these interventions.

Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders

Deadline: January 15, 2017

The purpose of this Funding Opportunity Announcement (FOA) is to support confirmatory efficacy testing of non-pharmacological therapeutic and preventive interventions for mental disorders in adults and children that address unmet therapeutic needs, and are consistent with the NIMH emphasis on the experimental therapeutics approach. In this approach, clinical trials should be designed to increase knowledge of the relationship between underlying disease processes and the mechanisms of action through which any intervention produces therapeutic change.